The Unusual Suspects for the Week Ahead (BRK-A, BRK-B, CLDA, GOOG, HUGH, MOS, NVDA, PBY, CRM, SWKS, SBIB, WMG, WWE)

There are many new characters in this week’s installment of “The Unusual Suspects” for the week ahead.  We have tracked news and added color on each where applicable.  The cast of characters in “The Unusual Suspects” includes Berkshire Hathaway Inc. (NYSE: BRK-B) (NYSE: BRK-A), Clinical Data Inc. (NASDAQ: CLDA), Google Inc. (NASDAQ: GOOG), Hughes Communications, Inc. (NASDAQ: HUGH), The Mosaic Co. (NYSE: MOS), NVIDIA Corporation (NASDAQ: NVDA), Pep Boys – Manny, Moe & Jack (NYSE: PBY), Salesforce.com (NYSE: CRM), Skyworks Solutions Inc. (NASDAQ: SWKS), Sterling Bancshares Inc. (NASDAQ: SBIB), Warner Music Group Corp. (NYSE: WMG), and World Wrestling Entertainment Inc. (NYSE: WWE).

We have given a breakdown of what has come about on each and what to expect during the week ahead  if applicable.  You will notice that we did not include any earnings previews this week.  This is the crest of earnings season and we gave a full earnings preview on about 25 major companies reporting this coming week, 11 of which are DJIA components.  We have a separate issue on The Top 5 Analyst Calls of the Week that we released independently over the weekend as well.  There was also enough in research calls specific to biotech and drug companies that we released a Top BioHealth Research Calls of the Week.

Berkshire Hathaway Inc. (NYSE: BRK-B) (NYSE: BRK-A) was given the “Mr. Moneybags” cover article in Barron’s over the weekend.  The report calls that the billions and billions in new cash coming in from debt repayments and the huge increase in cash flow from operations could lead to a dividend in the next 12 to 18 months if Buffett doesn’t find another elephant of a deal.

Clinical Data Inc. (NASDAQ: CLDA) is back on the radar after the FDA approved its antidepressant drug Viibyrd.  Analysts already see potential peak sales above $2 billion as this antidepressant is believed to not interfere with sexual desire as much as in some rival drugs.  Shares closed at $15.03 on Friday and rose almost 15% to $17.24 in the Friday after-hours session.  The 52-week trading range is $10.87 to $22.39 and the consensus price target is already $29.67 per Thomson Reuters data.

Google Inc. (NASDAQ: GOOG) closed down on Friday after having been up originally after huge blowout earnings.  The ongoing problem is that of the lack of adult supervision.  Some say that making Larry Page CEO is good and that it is time, but with close to a $200 billion market cap there were at least some concerns that Google needs more.  If Apple is a model based upon the Steve Jobs news, something hard to exactly compare on a Apples-to-Googles basis, then the same 6.2% drop from after the news would come to another slide of close to 2% on a static basis.